156 related articles for article (PubMed ID: 6100423)
21. [Rapid determination of the synergy of clavulanic acid and beta lactams by measuring the intracellular ATP by bioluminescence].
Cornel E; Philippon A; Paul G; Guenounou M
Ann Microbiol (Paris); 1982; 133(3):365-77. PubMed ID: 6819796
[TBL] [Abstract][Full Text] [Related]
22. Comparative in vitro activities of amoxicillin-clavulanate, ampicillin-sulbactam and piperacillin-tazobactam against strains of Escherichia coli and proteus mirabilis harbouring known beta-lactamases.
Gatermann S; Marre R
Infection; 1991; 19(2):106-9. PubMed ID: 1646771
[TBL] [Abstract][Full Text] [Related]
23. Beta-lactamase inhibitor combinations with extended-spectrum penicillins: factors influencing antibacterial activity against enterobacteriaceae and Pseudomonas aeruginosa.
Lister PD
Pharmacotherapy; 2000 Sep; 20(9 Pt 2):213S-218S; discussion 224S-228S. PubMed ID: 11001328
[TBL] [Abstract][Full Text] [Related]
24. Pseudomonas aeruginosa and Acinetobacter calcoaceticus: in vitro susceptibility of 150 clinical isolates to five beta-lactam antibiotics and tobramycin.
Dibb WL; Asphaug Kjellevold V; Digranes A
Chemotherapy; 1983; 29(5):332-6. PubMed ID: 6311491
[TBL] [Abstract][Full Text] [Related]
25. Comparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam.
Kuck NA; Jacobus NV; Petersen PJ; Weiss WJ; Testa RT
Antimicrob Agents Chemother; 1989 Nov; 33(11):1964-9. PubMed ID: 2558615
[TBL] [Abstract][Full Text] [Related]
26. Detection, distribution and inhibition of Branhamella catarrhalis beta-lactamases.
Philippon A; Riou JY; Guibourdenche M; Sotolongo F
Drugs; 1986; 31 Suppl 3():64-9. PubMed ID: 3015547
[TBL] [Abstract][Full Text] [Related]
27. In vitro comparison of N-formimidoyl thienamycin (MK0787) and Azlocillin with three aminoglycosides and ticarcillin against Pseudomonas aeruginosa.
Matzkowitz AJ; Baltch AL; Smith RP; Sutphen NT; Hammer MC; Conroy JV
Antimicrob Agents Chemother; 1982 Apr; 21(4):685-7. PubMed ID: 6805426
[TBL] [Abstract][Full Text] [Related]
28. N-formimidoyl-thienamycin and norfloxacin against multiple-resistant Pseudomonas aeruginosa strains. Combined in vitro activity and comparison with 14 other antibiotics.
Martino P; Venditti M; Valente B; Brandimarte C; Serra P
Drugs Exp Clin Res; 1985; 11(4):247-51. PubMed ID: 3939121
[TBL] [Abstract][Full Text] [Related]
29. Comparative activity of meropenem against Pseudomonas aeruginosa strains with well-characterized resistance mechanisms.
Livermore DM; Yang YJ
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():149-59. PubMed ID: 2553657
[TBL] [Abstract][Full Text] [Related]
30. Antibacterial activity of imipenem: the first thienamycin antibiotic.
Kropp H; Gerckens L; Sundelof JG; Kahan FM
Rev Infect Dis; 1985; 7 Suppl 3():S389-410. PubMed ID: 3931196
[TBL] [Abstract][Full Text] [Related]
31. In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanisms.
Chen HY; Livermore DM
J Antimicrob Chemother; 1994 May; 33(5):949-58. PubMed ID: 8089068
[TBL] [Abstract][Full Text] [Related]
32. Effect of pH on activities of novel beta-lactamases and beta-lactamase inhibitors against these beta-lactamases.
Ohsuka S; Arakawa Y; Horii T; Ito H; Ohta M
Antimicrob Agents Chemother; 1995 Aug; 39(8):1856-8. PubMed ID: 7486932
[TBL] [Abstract][Full Text] [Related]
33. Selection of variants of Pseudomonas aeruginosa resistant of Beta-lactam antibiotics.
Gwynn MN; Rolinson GN
Infection; 1980; 8(2):73-80. PubMed ID: 6771215
[TBL] [Abstract][Full Text] [Related]
34. Effects of inducible beta-lactamase and antimicrobial resistance upon the activity of newer beta-lactam antibiotics against Pseudomonas aeruginosa.
Hoffman TA; Cleary TJ; Bercuson DH
J Antibiot (Tokyo); 1981 Oct; 34(10):1334-40. PubMed ID: 6796556
[TBL] [Abstract][Full Text] [Related]
35. Beta-lactamase inhibitors from laboratory to clinic.
Bush K
Clin Microbiol Rev; 1988 Jan; 1(1):109-23. PubMed ID: 3060240
[TBL] [Abstract][Full Text] [Related]
36. Activity of 13 beta-lactam agents combined with BRL 42715 against beta-lactamase producing gram-negative bacteria compared to combinations with clavulanic acid, tazobactam and sulbactam.
Piddock LJ; Jin YF; Turner HL
J Antimicrob Chemother; 1993 Jan; 31(1):89-103. PubMed ID: 8383105
[TBL] [Abstract][Full Text] [Related]
37. Frequency of beta-lactamases that are markedly active against carbenicillin in the Pseudomonas aeruginosa strains isolated in a medical school hospital.
Jouvenot M; Bonin P; Michel-Briand Y
J Antimicrob Chemother; 1983 Nov; 12(5):451-8. PubMed ID: 6423610
[TBL] [Abstract][Full Text] [Related]
38. Variation in the potentiation of beta-lactam antibiotic activity by clavulanic acid and sulbactam against multiply antibiotic-resistant bacteria.
Aldridge KE; Sanders CV; Marier RL
J Antimicrob Chemother; 1986 Apr; 17(4):463-9. PubMed ID: 3011724
[TBL] [Abstract][Full Text] [Related]
39. Effect of clavulanic acid, sulbactam and tazobactam on three different beta-lactamases from Bacteroides uniformis, Clostridium butyricum and Fusobacterium nucleatum.
Hedberg M; Lindqvist L; Tunér K; Nord CE
J Antimicrob Chemother; 1992 Jul; 30(1):17-25. PubMed ID: 1331018
[TBL] [Abstract][Full Text] [Related]
40. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
Sader HS; Tosin I; Sejas L; Miranda E
Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
